XML 28 R15.htm IDEA: XBRL DOCUMENT v3.25.1
Stock-Based Compensation and Benefit Plans
 9 Months Ended
Mar. 29, 2025
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation and Benefit Plans Stock-Based Compensation and Benefit Plans
The Company’s 2024 Incentive Plan provides for equity and liability awards to employees and non-employee directors with service and performance vesting conditions in the form of stock options, stock appreciation rights (SARs), restricted stock, restricted stock units, stock awards, stock units, performance shares, performance units, and other stock-based or cash-based awards. At March 29, 2025, 1,595,362 shares were available for grant. Compensation cost is recognized on a straight-line basis over the requisite employee service period, which is generally the vesting period, and is recorded as employee compensation expense in cost of goods sold, research, development and engineering, and selling, general and administrative expenses. Share-based compensation is recognized only for those awards that are expected to vest. For SARs awards forfeitures are estimated at the date of grant based on historical experience and future expectations. Due to a lack of historical experience and a different grant pool than SARs, forfeitures for restricted stock units are accounted for prospectively as they occur.
Stock Appreciation Rights
In addition to service conditions, SARs contain a performance condition. The additional performance condition is based upon the achievement of Return on Invested Capital (ROIC) goals relative to a peer group. All awards with performance conditions are evaluated quarterly to determine the likelihood that performance metrics will be achieved during the performance period. These awards are charged to compensation expense over the requisite service period based on the number of shares expected to vest. If the performance and service conditions are attained, then the SARs cliff vest after the completion of the three-year period from date of grant and expire five years from date of grant.
SARsAggregate
Intrinsic
Value (in
thousands)		Weighted
Average
Exercise
Price		Weighted
Average
Remaining
Contractual
Life (in
years)
Balance, July 1, 2023626,250 — $6.41 2.2
SARs forfeited(137,500)6.94 
SARs expired(101,250)8.17 
Balance, March 30, 2024387,500 $— $5.78 1.8
Balance, June 30, 2024387,500 — $5.78 1.8
SARs forfeited(136,250)7.17 
SARs expired(115,000)4.93 
Balance, March 29, 2025136,250 $— $5.10 2.3
Exercisable at March 29, 2025— — — —

The Black-Scholes option valuation model is used by the Company for estimating the fair value of SARs. Option valuation models require the input of highly subjective assumptions, particularly for the expected term and expected stock price volatility. Changes in these assumptions can materially affect the fair value estimates. There were no SARs granted during the three or nine months ended March 29, 2025 and March 30, 2024.
Share-based compensation expense is recognized only for those awards that are expected to vest, with forfeitures estimated at the date of grant based on the Company’s historical experience and future expectations. This forfeiture rate will be revised, if necessary, in subsequent periods if actual forfeitures differ from the amount estimated. No SARs expense was recognized during the three months ended March 29, 2025 and $52,000 was recognized during the three months ended March 30, 2024. Total SARs expense recognized during the nine months ended March 29, 2025 and March 30, 2024 was approximately $(139,000) and $164,000, respectively
There were no SARs exercised during the three or nine month periods ended March 29, 2025 or March 30, 2024.
As of March 29, 2025, there is no unrecognized compensation expense for SARs awards due to unachieved performance.
Restricted Stock Units
The Company grants restricted stock units that have a performance condition and/or a service condition. Restricted stock units with only a service condition generally vest in equal annual installments over a maximum of three years. Certain restricted stock units are granted with a performance condition. The final number of shares issued will be determined annually based on the achievement of annual financial targets. Forfeitures for restricted stock units are accounted for prospectively as they occur. The fair value of restricted stock units is the market close price on the date of grant.
During the three months ended March 29, 2025, the Company did not grant any restricted stock units. Total restricted stock unit expense recognized during the three and nine months ended March 29, 2025 was approximately $26,000 and $250,000, respectively. During the nine months ended March 29, 2025, the Company granted 329,457 restricted stock units at a weighted average grant date fair value of $4.52 per share, none of which were granted during the third quarter.
As of March 29, 2025, total unrecognized compensation expense on restricted stock units was $1.0 million, which is expected to be recognized over a weighted average period of approximately 2.2 years.